RAPT Therapeutics Ownership | Who Owns RAPT Therapeutics?

RAPT Therapeutics Ownership Summary

RAPT Therapeutics is owned by 243.51% institutional investors, 0.42% insiders. Tcg crossover management is the largest institutional shareholder, holding 33.76% of RAPT shares. Fidelity Growth Compy Commingled Pl O is the top mutual fund, with 5.73% of its assets in RAPT Therapeutics shares.

RAPT Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	RAPT Therapeutics	243.51%	0.42%	-143.93%
Sector	Healthcare Stocks	278.70%	10.61%	-189.31%
Industry	Biotech Stocks	63.84%	10.66%	25.50%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Tcg crossover management	13.14M	33.76%	$19.75M
Orbimed advisors	13.14M	33.76%	$20.75M
Foresite capital management vi	12.50M	32.13%	$19.75M
Bvf inc/il	9.24M	23.74%	$14.60M
Redmile group	6.48M	16.64%	$10.23M
Deep track capital, lp	6.01M	15.45%	$9.50M
Perceptive advisors	5.88M	15.11%	$9.29M
Fmr	5.23M	13.45%	$8.27M
Vanguard group	2.94M	7.56%	$4.65M
Blackrock	2.44M	6.32%	$7.44M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Foresite capital management vi	12.50M	8.80%	$19.75M
Column group	1.33M	3.77%	$2.10M
Tcg crossover management	13.14M	1.93%	$19.75M
Redmile group	6.48M	0.71%	$10.23M
Bvf inc/il	9.24M	0.49%	$14.60M
Orbimed advisors	13.14M	0.43%	$20.75M
Adar1 capital management	1.17M	0.37%	$1.86M
Deep track capital, lp	6.01M	0.35%	$9.50M
Ghost tree capital	300.00K	0.29%	$915.00K
Perceptive advisors	5.88M	0.26%	$9.29M

Top Buyers

Holder	Shares	% Assets	Change
Tcg crossover management	13.14M	1.93%	13.14M
Orbimed advisors	13.14M	0.43%	13.14M
Foresite capital management vi	12.50M	8.80%	12.50M
Bvf inc/il	9.24M	0.49%	9.24M
Deep track capital, lp	6.01M	0.35%	6.01M

Top Sellers

Holder	Shares	% Assets	Change
Medicxi ventures management (jersey)	-	-	-22.35M
Column group	1.33M	3.77%	-1.35M
Affinity asset advisors	-	-	-1.00M
Morgan stanley	1.18M	0.00%	-726.44K
Kingdon capital management	-	-	-575.00K

New Positions

Holder	Shares	% Assets	Change	Value
Tcg crossover management	13.14M	1.93%	13.14M	$19.75M
Orbimed advisors	13.14M	0.43%	13.14M	$20.75M
Foresite capital management vi	12.50M	8.80%	12.50M	$19.75M
Bvf inc/il	9.24M	0.49%	9.24M	$14.60M
Deep track capital, lp	6.01M	0.35%	6.01M	$9.50M

Sold Out

Holder	Change
Farther finance advisors	-2.00
Quest partners	-5.00
Nelson, van denburg & campbell wealth management group	-7.00
Us bancorp \de\	-11.00
Gamma investing	-27.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Mar 31, 2025	91	-4.21%	131,135,934	3.35%	243	0.23%	41	-33.87%	26	30.00%
Dec 31, 2024	90	-5.26%	114,301,746	283.56%	293	5.01%	57	50.00%	20	-25.93%
Sep 30, 2024	95	-18.10%	29,799,990	-6.32%	76	1.13%	38	-32.14%	27	-18.18%
Jun 30, 2024	116	-17.14%	31,809,166	-0.17%	82	1.20%	56	-25.33%	33	10.00%
Mar 31, 2024	140	19.66%	31,861,728	-8.92%	83	1.00%	75	19.05%	30	-14.29%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Fidelity Growth Compy Commingled Pl O	2.00M	5.73%	-
Vanguard Total Stock Mkt Idx Inv	5.51M	4.17%	-
Fidelity Growth Compy Commingled Pl S	2.05M	1.56%	21.11K
Fidelity Growth Company Fund	1.49M	1.13%	-18.17K
Vanguard Institutional Extnd Mkt Idx Tr	1.44M	1.09%	-
Vanguard US Total Market Shares ETF	1.12M	0.85%	-
iShares Biotechnology ETF	201.44K	0.58%	-
iShares Russell 2000 ETF	703.88K	0.53%	-
Fidelity Growth Company K6	481.38K	0.36%	-2.94K
Federated Hermes MDT SCC Institutional	461.23K	0.35%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Jan 05, 2024	Brockstedt Dirk G.	CHIEF SCIENTIFIC OFFICER	Sell	$20.46K
Dec 21, 2023	HO WILLIAM	Chief Medical Officer	Sell	$54.20K
Nov 28, 2023	HO WILLIAM	Chief Medical Officer	Sell	$20.58K
Oct 03, 2023	HO WILLIAM	Chief Medical Officer	Sell	$39.42K
Aug 18, 2023	HO WILLIAM	Chief Medical Officer	Sell	$47.30K

Insider Transactions Trends

Date	Buy	Sell
2024 Q4	-	-
2024 Q2	-	-
2024 Q1	-	1
2023 Q4	-	3
2023 Q3	-	1

RAPT Ownership FAQ

Who Owns RAPT Therapeutics?

RAPT Therapeutics shareholders are primarily institutional investors at 243.51%, followed by 0.42% insiders and -143.93% retail investors. The average institutional ownership in RAPT Therapeutics's industry, Biotech Stocks , is 63.84%, which RAPT Therapeutics exceeds.

Who owns the most shares of RAPT Therapeutics?

RAPT Therapeutics’s largest shareholders are Tcg crossover management (13.14M shares, 33.76%), Orbimed advisors (13.14M shares, 33.76%), and Foresite capital management vi (12.5M shares, 32.13%). Together, they hold 99.66% of RAPT Therapeutics’s total shares outstanding.

Does Blackrock own RAPT Therapeutics?

Yes, BlackRock owns 6.32% of RAPT Therapeutics, totaling 2.44M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 7.44M$. In the last quarter, BlackRock decreased its holdings by -32.323K shares, a -1.31% change.

Who is RAPT Therapeutics’s biggest shareholder by percentage of total assets invested?

Foresite capital management vi is RAPT Therapeutics’s biggest shareholder by percentage of total assets invested, with 8.80% of its assets in 12.5M RAPT Therapeutics shares, valued at 19.75M$.

Who is the top mutual fund holder of RAPT Therapeutics shares?

Fidelity Growth Compy Commingled Pl O is the top mutual fund holder of RAPT Therapeutics shares, with 5.73% of its total shares outstanding invested in 2M RAPT Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools